Fibrodone 801mg Tablet contains Pirfenidone, an antifibrotic and anti-inflammatory agent primarily used in the treatment of idiopathic pulmonary fibrosis (IPF), a chronic and progressive lung disease characterized by scarring of lung tissue. Pirfenidone works by inhibiting the synthesis of transforming growth factor-beta (TGF-β) and other cytokines involved in the fibrotic process, thereby reducing fibrosis and inflammation in the lungs. This action helps to slow the progression of IPF, improve lung function, and enhance the quality of life for patients. Fibrodone is typically prescribed under medical supervision and should be taken orally with food to minimize gastrointestinal side effects. Common adverse effects may include nausea, rash, fatigue, dizziness, and photosensitivity, so patients are advised to avoid excessive sun exposure and use protective measures. Liver function tests are recommended periodically during treatment to monitor for potential hepatotoxicity. Fibrodone is contraindicated in patients with known hypersensitivity to Pirfenidone or its components. It is important to follow the prescribed dosage regimen strictly and consult a healthcare professional before starting or discontinuing the medication. Overall, Fibrodone 801mg Tablet offers a valuable therapeutic option for managing idiopathic pulmonary fibrosis and improving patient outcomes.